Abstracts

Article Nº AJ17-5

5.

HEMATOLOGY

G. Ascoli 5.01 AN ACCURATE AND USEFUL TOOL IN MULTIPLE MYELOMA FOR DISEASE MANAGEMENT: TECHNETIUM 99M-SESTAMIBI SCINTIGRAPHY   R.J. Bennink 5.02 IN VIVO ASSESSMENT OF 111IN LABELLED LYMPHOCYTE GUT HOMING IN A TNBS COLITIS MOUSE MODEL DETERMINED BY DEDICATED ANIMAL PINHOLE SPECT   F.C. Hua 5.03 EFFECT OF WHOLE-BODY 18F-FDG PET ON DETECTION AND CLINICAL STAGING OF NON-HODGKIN'S LYMPHOMA   P.Y. Li 5.04 STUDY OF RADIATION SYNOVECTOMY USING 188RE-SULFIDE IN HEMOPHILIC ARTHRITIS   O. Lindén 5.05 RADIOIMMUNOTHERAPY WITH Y-90-EPRATUZUMAB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA. A FRACTIONATED DOSE-ESCALATION STUDY   E.P. Parma 5.06 LIMPHOMAS: CORRELATION BETWEEN 67GA SCINTIGRAPHY AND TRANSFERRIN RECEPTOR EXPRESSION IN LYMPHOMAS   S.V. Solav 5.07 RADIATION SYNOVECTOMY IN VARIOUS DISORDERS OF THE JOINTS   R.F. Wang 5.08 THE VALUE OF CLINICAL STAGING OF MALIGNANT LYMPHOMA AND EVALUATING THE THERAPEUTIC EFFECTIVE WITH SPECT-PET F-18-FDG METABOLIC IMAGING   G.A. Wiseman 5.09 RADIOIMMUNOTHERAPY OF INDOLENT NON-HODGKIN'S LYMPHOMA WITH YTTRIUM-90 LABELED ANTI-CD20 MONOCLONAL ANTIBODY THERAPY DOES NOT PRECLUDE SUBSEQUENT CHEMOTHERAPY OR AUTOLOGOUS HEMATOLOGIC STEM CELL TRANSPLANTATION THERAPY IN MOST PATIENTS   G.A. Wiseman 5.10 RADIOIMMUNOTHERAPY OF NON-HODGKIN'S LYMPHOMA USING YTTRIUM-90 LABELED ANTI-CD20 MONOCLONAL ANTIBODY THERAPY AT MAYO CLINIC: A SINGLE INSTITUTION EXPERIENCE

Cardiovascular |Cost Benefits|Endocrinology |Gastroenterology |Hematology |Infection| Musculoskeletal |Nephro-Urology |Neuro-Psychiatric Disorders |Oncology Diagnosis |Oncology Therapy |Pediatrics|Physics |Pulmonary |Radiopharmacy |Technology

Sitio desarrollado por SISIB - Universidad de Chile